Bill Sponsors: NJ S919 | 2020-2021 | Regular Session

Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2020-01-27 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S919 Detail]

Text: Latest bill text (Introduced) [HTML]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Senator Troy Singleton [D]PrimarySponsored BillsSD-007FollowTheMoneyBallotpediaVoteSmart

Social Comments on NJ S919

feedback